152 related articles for article (PubMed ID: 9770740)
1. [Gopten (trandolapril) in the treatment of chronic heart failure in patients with ischemic heart disease].
Kakhnovskiĭ IM; Fomina IG; Ostroumov EL; Lepeshkov VM; Gaĭdamakina NE; Kaveshnikova OV; Markova ZS; Lugovaia EL
Ter Arkh; 1998; 70(8):29-33. PubMed ID: 9770740
[TBL] [Abstract][Full Text] [Related]
2. Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
Hansen JF
J Hypertens Suppl; 1998 Jan; 16(1):S71-4. PubMed ID: 9534101
[TBL] [Abstract][Full Text] [Related]
3. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
4. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. [Viable myocardium: comparative evaluation of surgical and pharmacological treatment of patients with ischemic heart disease, post-infarct cardiosclerosis and chronic cardiac failure].
Saidova MA; Belenkov IuN; Akchurin RS; Sergienko VB; Khodareva EN; Kostrova VV
Ter Arkh; 2002; 74(2):60-4. PubMed ID: 11899830
[TBL] [Abstract][Full Text] [Related]
7. [Effects of perstarium on the systolic and diastolic functions of the myocardium in patients with chronic cardiac failure].
Fomina IG; Georgadze ZO; Sinitsyna MG; Gaĭdamakina NE; Nagieva AZ; Matveev VV
Klin Med (Mosk); 2001; 79(8):20-3. PubMed ID: 11588778
[TBL] [Abstract][Full Text] [Related]
8. The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.
Buch P; Rasmussen S; Abildstrom SZ; Køber L; Carlsen J; Torp-Pedersen C;
Eur Heart J; 2005 Jan; 26(2):145-52. PubMed ID: 15618070
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
[TBL] [Abstract][Full Text] [Related]
10. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
Tereshchenko SN; Demidova IV; Kobalava ZhD; Moiseev VS
Ter Arkh; 2002; 74(4):56-8. PubMed ID: 12043242
[TBL] [Abstract][Full Text] [Related]
11. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.
Elhendy A; Sozzi F; van Domburg RT; Bax JJ; Schinkel AF; Roelandt JR; Poldermans D
Am J Cardiol; 2005 Aug; 96(4):469-73. PubMed ID: 16098295
[TBL] [Abstract][Full Text] [Related]
12. [The clinical efficacy of the first Russian angiotensin-converting enzyme inhibitor methiopril in patients with heart failure].
Glezer MG; Orlova LL; Titova DKh; Shvarts GIa
Klin Med (Mosk); 1995; 73(3):49-51. PubMed ID: 8577109
[TBL] [Abstract][Full Text] [Related]
13. Ischemic versus non-ischemic heart failure: should the etiology be determined?
Follath F
Heart Fail Monit; 2001; 1(4):122-5. PubMed ID: 12634896
[TBL] [Abstract][Full Text] [Related]
14. What is the optimal medical management of ischemic heart failure?
Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
[TBL] [Abstract][Full Text] [Related]
15. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
16. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
17. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
Sami M
Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
[TBL] [Abstract][Full Text] [Related]
19. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
Banerjee A; Talreja A; Sonnenblick EH; LeJemtel TH
Mt Sinai J Med; 2003 Sep; 70(4):225-31. PubMed ID: 12968195
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy of treatment with the angiotensin-converting enzyme inhibitor ramipril in patients with congestive heart failure of rheumatic etiology].
Karakin AA; Khrustalev OA; Bol'shakova MA; Forsilov VE
Ter Arkh; 1996; 68(2):43-6. PubMed ID: 8771657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
